{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T12:03:15Z","timestamp":1784376195753,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,18]]},"DOI":"10.7759\/cureus.112902","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:34:57Z","timestamp":1784374497000},"source":"Crossref","is-referenced-by-count":0,"title":["DNA Methylation at Core N-Methyl-D-Aspartate (NMDA) Receptor Genes Reveals a Glutamatergic Signature of Aging in Post-COVID Whole Blood With Implications for Long-COVID Neuropsychiatric Sequelae"],"prefix":"10.7759","author":[{"given":"Ngo","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis HE","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023, 21:133-46. 10.1038\/s41579-022-00846-2","journal-title":"Nat Rev Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su Y","year":"2022","unstructured":"Su Y, Yuan D, Chen DG, et al.. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022, 185:881-95.e20. 10.1016\/j.cell.2022.01.014","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-10-r115","article-title":"DNA methylation age of human tissues and cell types","volume":"14","author":"Horvath S","year":"2013","unstructured":"Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013, 14:R115. 10.1186\/gb-2013-14-10-r115","journal-title":"Genome Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5483\/bmbrep.2017.50.11.175","article-title":"DNA methylation-based age prediction from various tissues and body fluids","volume":"50","author":"Jung SE","year":"2017","unstructured":"Jung SE, Shin KJ, Lee HY. DNA methylation-based age prediction from various tissues and body fluids. BMB Rep. 2017, 50:546-53. 10.5483\/bmbrep.2017.50.11.175","journal-title":"BMB Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12349","article-title":"DNA methylation and healthy human aging","volume":"14","author":"Jones MJ","year":"2015","unstructured":"Jones MJ, Goodman SJ, Kobor MS. DNA methylation and healthy human aging. Aging Cell. 2015, 14:924-32. 10.1111\/acel.12349","journal-title":"Aging Cell"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5HI0720-466R","article-title":"Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19","volume":"110","author":"Corley MJ","year":"2021","unstructured":"Corley MJ, Pang AP, Dody K, et al.. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19. J Leukoc Biol. 2021, 110:21-6. 10.1002\/JLB.5HI0720-466R","journal-title":"J Leukoc Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116151","article-title":"Evidence for biological age acceleration and telomere shortening in COVID-19 survivors","volume":"22","author":"Mongelli A","year":"2021","unstructured":"Mongelli A, Barbi V, Gottardi Zamperla M, et al.. Evidence for biological age acceleration and telomere shortening in COVID-19 survivors. Int J Mol Sci. 2021, 22:6151. 10.3390\/ijms22116151","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01724-9","article-title":"Epigenetic patterns, accelerated biological aging, and enhanced epigenetic drift detected 6 months following COVID-19 infection: insights from a genome-wide DNA methylation study","volume":"16","author":"Calzari L","year":"2024","unstructured":"Calzari L, Dragani DF, Zanotti L, et al.. Epigenetic patterns, accelerated biological aging, and enhanced epigenetic drift detected 6 months following COVID-19 infection: insights from a genome-wide DNA methylation study. Clin Epigenetics. 2024, 16:112. 10.1186\/s13148-024-01724-9","journal-title":"Clin Epigenetics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti P","year":"2013","unstructured":"Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci. 2013, 14:383-400. 10.1038\/nrn3504","journal-title":"Nat Rev Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.120.000131","article-title":"Structure, function, and pharmacology of glutamate receptor ion channels","volume":"73","author":"Hansen KB","year":"2021","unstructured":"Hansen KB, Wollmuth LP, Bowie D, et al.. Structure, function, and pharmacology of glutamate receptor ion channels. Pharmacol Rev. 2021, 73:298-487. 10.1124\/pharmrev.120.000131","journal-title":"Pharmacol Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2010.10.022","article-title":"Metabotropic glutamate receptors: from the workbench to the bedside","volume":"60","author":"Nicoletti F","year":"2011","unstructured":"Nicoletti F, Bockaert J, Collingridge GL, et al.. Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology. 2011, 60:1017-41. 10.1016\/j.neuropharm.2010.10.022","journal-title":"Neuropharmacology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2969","article-title":"From glutamate co-release to vesicular synergy: vesicular glutamate transporters","volume":"12","author":"El Mestikawy S","year":"2011","unstructured":"El Mestikawy S, Wall\u00e9n-Mackenzie A, Fortin GM, Descarries L, Trudeau LE. From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat Rev Neurosci. 2011, 12:204-16. 10.1038\/nrn2969","journal-title":"Nat Rev Neurosci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-014-1167-5","article-title":"The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells","volume":"121","author":"Ganor Y","year":"2014","unstructured":"Ganor Y, Levite M. The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells. J Neural Transm (Vienna). 2014, 121:983-1006. 10.1007\/s00702-014-1167-5","journal-title":"J Neural Transm (Vienna)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/25424823261433953","article-title":"The Cheung Glutamatergic Regimen as a candidate for primary and secondary prevention of Alzheimer's disease onset","volume":"10","author":"Cheung N","year":"2026","unstructured":"Cheung N. The Cheung Glutamatergic Regimen as a candidate for primary and secondary prevention of Alzheimer's disease onset. J Alzheimers Dis Rep. 2026, 10:25424823261433953. 10.1177\/25424823261433953","journal-title":"J Alzheimers Dis Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2026.1751605","article-title":"DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs","volume":"17","author":"Cheung N","year":"2026","unstructured":"Cheung N. DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs. Front Psychiatry. 2026, 17:1751605. 10.3389\/fpsyt.2026.1751605","journal-title":"Front Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"28","author":"Kanehisa M","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000, 28:27-30. 10.1093\/nar\/28.1.27","journal-title":"Nucleic Acids Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2015.02.002","article-title":"Reconfiguration of DNA methylation in aging","volume":"151","author":"Zampieri M","year":"2015","unstructured":"Zampieri M, Ciccarone F, Calabrese R, Franceschi C, B\u00fcrkle A, Caiafa P. Reconfiguration of DNA methylation in aging. Mech Ageing Dev. 2015, 151:60-70. 10.1016\/j.mad.2015.02.002","journal-title":"Mech Ageing Dev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12005","article-title":"Methylation of ELOVL2 gene as a new epigenetic marker of age","volume":"11","author":"Garagnani P","year":"2012","unstructured":"Garagnani P, Bacalini MG, Pirazzini C, et al.. Methylation of ELOVL2 gene as a new epigenetic marker of age. Aging Cell. 2012, 11:1132-4. 10.1111\/acel.12005","journal-title":"Aging Cell"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glw185","article-title":"Systemic age-associated DNA hypermethylation of ELOVL2 gene: in vivo and in vitro evidences of a cell replication process","volume":"72","author":"Bacalini MG","year":"2017","unstructured":"Bacalini MG, Deelen J, Pirazzini C, et al.. Systemic age-associated DNA hypermethylation of ELOVL2 gene: in vivo and in vitro evidences of a cell replication process. J Gerontol A Biol Sci Med Sci. 2017, 72:1015-23. 10.1093\/gerona\/glw185","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2015.1080413","article-title":"Improved age determination of blood and teeth samples using a selected set of DNA methylation markers","volume":"10","author":"Bekaert B","year":"2015","unstructured":"Bekaert B, Kamalandua A, Zapico SC, Van de Voorde W, Decorte R. Improved age determination of blood and teeth samples using a selected set of DNA methylation markers. Epigenetics. 2015, 10:922-30. 10.1080\/15592294.2015.1080413","journal-title":"Epigenetics"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li H","year":"2018","unstructured":"Li H, Zuo J, Tang W. Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases. Front Pharmacol. 2018, 9:1048. 10.3389\/fphar.2018.01048","journal-title":"Front Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-017-1636-0","article-title":"DNA methylation in ELOVL2 and C1orf132 correctly predicted chronological age of individuals from three disease groups","volume":"132","author":"Sp\u00f3lnicka M","year":"2018","unstructured":"Sp\u00f3lnicka M, Po\u015bpiech E, Pep\u0142o\u0144ska B, et al.. DNA methylation in ELOVL2 and C1orf132 correctly predicted chronological age of individuals from three disease groups. Int J Legal Med. 2018, 132:1-11. 10.1007\/s00414-017-1636-0","journal-title":"Int J Legal Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh C","year":"2022","unstructured":"Phetsouphanh C, Darley DR, Wilson DB, et al.. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022, 23:210-6. 10.1038\/s41590-021-01113-x","journal-title":"Nat Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01724-6","article-title":"Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2","volume":"25","author":"Yin K","year":"2024","unstructured":"Yin K, Peluso MJ, Luo X, et al.. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024, 25:218-25. 10.1038\/s41590-023-01724-6","journal-title":"Nat Immunol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2012.06.001","article-title":"CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease","volume":"99","author":"Bhat S","year":"2012","unstructured":"Bhat S, Dao DT, Terrillion CE, Arad M, Smith RJ, Soldatov NM, Gould TD. CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog Neurobiol. 2012, 99:1-14. 10.1016\/j.pneurobio.2012.06.001","journal-title":"Prog Neurobiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109262","article-title":"CACNA1C (Ca(V)1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: advances from functional genomics and pharmacoepidemiology","volume":"220","author":"Harrison PJ","year":"2022","unstructured":"Harrison PJ, Husain SM, Lee H, et al.. CACNA1C (Ca(V)1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: advances from functional genomics and pharmacoepidemiology. Neuropharmacology. 2022, 220:109262. 10.1016\/j.neuropharm.2022.109262","journal-title":"Neuropharmacology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.05.014","article-title":"Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity","volume":"26","author":"Schafer PH","year":"2014","unstructured":"Schafer PH, Parton A, Capone L, et al.. Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity. Cell Signal. 2014, 26:2016-29. 10.1016\/j.cellsig.2014.05.014","journal-title":"Cell Signal"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/513868-dna-methylation-at-core-n-methyl-d-aspartate-nmda-receptor-genes-reveals-a-glutamatergic-signature-of-aging-in-post-covid-whole-blood-with-implications-for-long-covid-neuropsychiatric-sequelae","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:34:58Z","timestamp":1784374498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/513868-dna-methylation-at-core-n-methyl-d-aspartate-nmda-receptor-genes-reveals-a-glutamatergic-signature-of-aging-in-post-covid-whole-blood-with-implications-for-long-covid-neuropsychiatric-sequelae"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.112902","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,18]]}}}